Novartis
NVS
NVS
1,132 hedge funds and large institutions have $26.2B invested in Novartis in 2019 Q1 according to their latest regulatory filings, with 114 funds opening new positions, 419 increasing their positions, 396 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6% more repeat investments, than reductions
Existing positions increased: 419 | Existing positions reduced: 396
0.04% more ownership
Funds ownership: 11.93% → 11.97% (+0.04%)
3% less funds holding in top 10
Funds holding in top 10: 40 → 39 (-1)
Holders
1,132
Holding in Top 10
39
Calls
$146M
Puts
$94.9M
Top Buyers
| 1 | +$160M | |
| 2 | +$136M | |
| 3 | +$93.3M | |
| 4 |
Mawer Investment Management
Calgary,
Alberta, Canada
|
+$88.1M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$68.2M |
Top Sellers
| 1 | -$124M | |
| 2 | -$64.7M | |
| 3 | -$60.6M | |
| 4 |
Boston Partners
Boston,
Massachusetts
|
-$56.2M |
| 5 |
MAM
Majedie Asset Management
London,
United Kingdom
|
-$56M |